Related Experiment Video
Updated: May 5, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Kidney disease and cardiovascular risk
Marcello Tonelli1, Marc A Pfeffer
1Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada.
Insights
Chronic kidney disease (CKD) accelerates cardiovascular disease due to risk factors and inflammation. Therapies for cardiovascular disease are underused in CKD patients, highlighting a need for further research.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Chronic kidney disease (CKD) is linked to increased cardiovascular disease (CVD) risk.
- Both traditional and non-traditional risk factors contribute to CVD in CKD patients.
- Inflammation, volume overload, and calcium-phosphate issues are key non-traditional factors.
Purpose of the Study:
- To review the epidemiology and pathophysiology of CVD in CKD.
- To discuss the implications of current knowledge for clinical practice and public health.
- To identify research gaps and opportunities in managing CVD in CKD.
Main Methods:
- Literature review and synthesis of existing research.
- Epidemiological data analysis.
- Pathophysiological mechanism exploration.
Main Results:
- CVD is highly prevalent and accelerated in patients with CKD.
- Underutilization of beneficial CVD therapies in mild-to-moderate CKD.
- Limited research on CVD therapies in kidney failure patients.
Conclusions:
- CKD significantly elevates CVD risk through multiple factors.
- Current therapeutic strategies for CVD are not optimally applied in CKD populations.
- Further research is crucial to improve CVD outcomes in individuals with kidney disease.
Abstract:
Kidney failure and chronic kidney disease (CKD) are associated with accelerated cardiovascular disease, apparently because of a high burden of traditional vascular risk factors and possibly nontraditional risk factors such as inflammation, chronic volume overload, and abnormal calcium-phosphate metabolism. Although the burden of cardiovascular disease in CKD patients is well documented, potentially beneficial therapies appear to be underused in mild to moderate CKD and are relatively understudied in those with kidney failure. This review describes the epidemiology and pathophysiology of cardiovascular disease in CKD. We also discuss the clinical and public health implications of current knowledge and outline opportunities for further research.
Related Concept Videos
Kidney Transplant I: Introduction
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Diabetic Nephropathy

